Thyroid cancers
Authors:
M. Hlaváčková
Authors‘ workplace:
Ředitelka: doc. RNDr. Běla Bendlová, CSc.
; Endokrinologický ústav, Praha
Published in:
Prakt. Lék. 2020; 100(2): 100-102
Category:
Case Report
Overview
The thyroid cancers are the 5th most common tumours in young age groups of our population. The most of these cancers are treated with long term complete remission lasting several decades of life. Eighty percent patients with diagnosed differentiated thyroid cancer exhibit 40 years survival. A survey of essential variants of thyroid tumours and their therapeutic options is provided. Special attention is paid to molecular genetic methods applied in both diagnosis and treatment of these tumours. The case of a rare variant of thyroid cancer is reported and an employment of novel methods in clinical practice and their contribution to new diagnostic and therapeutic procedures is demonstrated.
Keywords:
thyroid cancer – FNAC (fine needle aspiration cytology) – Molecular genetics – columnar variant of PTC – B-RAF mutation
Sources
1. Bendlová B, Dvořáková Š, Sýkorová V, a kol. Genetika nádorů štítné žlázy a jejich molekulárně cílená léčba. Onkologie 2011; 5(6): 325–327.
2. Vlček P, Neumann J. Karcinom štítné žlázy. Praha: Maxdorf 2002.
3. Bendlová B, Sýkorová V, Václavíková E, a kol. Nádory štítné žlázy u dětí a dospívajících a jejich molekulárně genetická podstata. Vnitř. Lék. 2016; 62(Supll 3): 40–44.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2020 Issue 2
Most read in this issue
- General overview of percutaneous endoscopic gastrostomy
- Anxiety of pregnant women – importance, risk factors, consequences
- Standard, neglected and new information about compression therapy with bandages
- Thyroid cancers